Home
  >  
Section 49
  >  
Chapter 48,222

An Advisory Committee Statement (ACS) . National Advisory Committee on Immunization (NACI) . Update: statement on influenza vaccination for the 2003-04 season

Tam, T.; Langley, J.

Canada Communicable Disease Report 30: 1-5

2004

ISSN/ISBN: 1188-4169
PMID: 15035403
Accession: 048221634
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering or using the vaccine should also be aware of the contents of the relevant product monograph(s). Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) of the Canadian licensed manufacturer(s) of the vaccine(s). Manufacturer(s) have sought approval of the vaccine(s) and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs.

PDF emailed within 1 workday: $29.90




Related References

2003: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season Canada Communicable Disease Report 29: 1-20
Orr, P. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season Canada Communicable Disease Report 30: 1-32
1998: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season Canada Communicable Disease Report 24: 1-12
2001: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season Canada Communicable Disease Report 27: 1-3
1996: National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1996-97 season Canada Communicable Disease Report 22(12): 89-97
2002: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination Canada Communicable Disease Report 28(Acs-1): 1-12
1990: National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1990-1991 season Canada Diseases Weekly Report 16(25): 117-121
Desai, S.; McGeer, A.; Quach-Thanh, C.; Elliott, D. 2010: Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-12): 1-21
Dawar, D.M.; Harris, M.T.; McNeil, D.S. 2012: Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 38(Acs-1): 1-62
Tan, B.; Ismail, S. 2010: Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-8): 1-26
De Serres, G. 2000: An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine Canada Communicable Disease Report 26: 1-8
2000: Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 19-20
1997: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention Canada Communicable Disease Report 23: 1-6
2000: Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 12-18
Campbell, A.; Ismail, S.; Tan, B. 2010: Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-10): 1-24
Ford-Jones, E.L.; Calvin, S. 2010: Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-14): 1-31
Tan, B.; Ismail, S. 2010: Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-7): 1-19
Gemmill, I. 2003: National Advisory Committee on Immunization (NACI). Statement on thimerosal Canada Communicable Disease Report 29: 1-10
2006: Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS) Canada Communicable Disease Report 32(Acs-2): 1-3
2006: Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS) Canada Communicable Disease Report 32(Acs-7): 1-27